English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Oct 15, 2025

Empower returns as presenting sponsor for Fight For Air Climb in Kansas City

+ Pharmaceuticals
Patient Daily | Oct 15, 2025

Baylor expert offers guidance on managing fall allergy risks

+ Pharmaceuticals
Patient Daily | Oct 15, 2025

Northwestern Medicine expands native gardens at McHenry Hospital for health and sustainability
+ Pharmaceuticals
Patient Daily | Oct 14, 2025

Duncan Cancer Center receives renewed NCI designation with $18 million grant
+ Pharmaceuticals
Patient Daily | Oct 14, 2025

Researchers restore fertility in mice with genetic infertility using mRNA therapy
+ Pharmaceuticals
Patient Daily | Oct 14, 2025

Dan L Duncan Comprehensive Cancer Center receives renewed NCI designation with $18 million grant
+ Pharmaceuticals
Patient Daily | Oct 13, 2025

Cardinal Institute policy analyst: 340B program 'has quietly become a $40B side business'
+ Pharmaceuticals
Patient Daily | Oct 13, 2025

American Lung Association in Rhode Island announces inaugural gala to support lung health

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes